The claimants were children of mothers who suffered from epilepsy and during their pregnancy, it is said, took an anti-epileptic drug (or anti-convulsant drug) called sodium valproate, which the defendants marketed Under the name Epilim. The claimants say that Epilim is a known teratogen, which crosses the placenta during pregnancy and is recognised to cause various deformities, and that therefore it is unsafe for all pregnant women whose fetuses are exposed to it.
Mr Justice Andrew Smith
[2007] EWHC 1860 (QB)
Bailii
England and Wales
Personal Injury
Updated: 10 December 2021; Ref: scu.261907